Mitsutoshi Satoh, Hina Sakurai, Megumi Nakamura, Kaito Hasegawa, Suzuna Sekine, Yuma Kato, Tomoya Shimura, Hiroyuki Tanaka, Naoko Ishii, Yui Utsunomiya, Senri Mizobuchi, Kaoru Hirose, Yayoi Kawano, and Takehisa Hanawa
Severe oral stomatitis in patients treated with 5-fluorouracil (5-FU) reduces their quality of life. Here, we investigated the healing effect of rebamipide, a drug used for treatment of gastric ulcers, on the area of acetic acid-induced stomatitis in Golden Syrian hamsters treated and untreated with 5-FU. We attempted to solubilize rebamipide by ternary grinding with rebamipide, polyvinylpyrrolidone K 30 (PVPK-30), and sodium dodecyl sulfate (1:5:1) to obtain a preparation termed GMS. Application of GM5 solution, containing 3.0 mg/mL rebamipide, significantly reduced the area of acetic acid-induced oral stomatitis lesions in 5-FU-untreated animals. It also considerably reduced the lesion area of acetic acid-induced oral stomatitis in 5-FU-treated animals. In 5-FU-treated animals, the time required for 50% reduction in the area of oral stomatitis was significantly shorter in those treated with solubilized rebamipide than in those that were not thus treated (P<0.05). These results suggest that solubilized rebamipide GM5 solution is able to heal acetic acid-induced oral stomatitis in both 5-FU-treated and -untreated animals. [ABSTRACT FROM AUTHOR]